Francesca Diomedi Camassei
Overview
Explore the profile of Francesca Diomedi Camassei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arena M, Labbadia R, Cappoli A, Spagnoletti G, Diomedi Camassei F, Emma F, et al.
J Nephrol
. 2024 Oct;
PMID: 39382784
Background: Primary hyperoxaluria type 1 is responsible for pediatric kidney failure in 1 to 2% of cases. Novel therapies based on RNA interference are changing the natural history of the...
2.
Ciceri S, Bertolotti A, Serra A, Gattuso G, Boschetti L, Capasso M, et al.
iScience
. 2024 Sep;
27(9):110684.
PMID: 39262773
Few studies investigated the genetics of relapsed Wilms tumor (WT), suggesting the gene, the microRNA processing genes, and the MYCN network as possibly involved in a relevant percentage of relapses....
3.
De Leo E, Taranta A, Raso R, Pezzullo M, Piccione M, Matteo V, et al.
Biomed Pharmacother
. 2024 Aug;
178:117236.
PMID: 39096619
In infantile nephropathic cystinosis, variants of the CTNS gene cause accumulation of cystine in lysosomes, causing progressive damage to most organs. Patients usually present before 1 year of age with...
4.
De Benedetti F, Diomedi Camassei F, Locatelli F
N Engl J Med
. 2024 May;
390(17):1629.
PMID: 38692298
No abstract available.
5.
Antonucci L, Fuiano L, Gargiulo A, Gianviti A, Onetti Muda A, Diomedi Camassei F, et al.
Pediatr Nephrol
. 2024 Jan;
39(6):1837-1846.
PMID: 38225439
Background: IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide. While studies have primarily focused on identifying risk factors for disease progression, very few data exist on the likelihood of...
6.
Pellegrino C, Forlini V, Lena F, Capitanucci M, Diomedi Camassei F, Castelli E, et al.
Biomedicines
. 2023 May;
11(5).
PMID: 37238971
Background: In the last twenty-five years, Onabotulinum Toxin A (BTX-A) has gained increasing popularity for neurogenic lower urinary tract dysfunction (NLUTD) treatment. To maintain its efficacy, repeated BTX-A intradetrusor injections...
7.
Salgado C, Alaggio R, Ciolfi A, Zin A, Diomedi Camassei F, Pedace L, et al.
Mod Pathol
. 2023 Feb;
36(2):100039.
PMID: 36853789
In the pediatric population, BCL6-correpresor gene (BCOR)-upregulated tumors include primitive myxoid mesenchymal tumors/undifferentiated sarcomas (PMMTI/UND), clear cell sarcomas of the kidney (CCSK), and high-grade neuroepithelial tumors (HG-NET). We investigated DNA...
8.
Annicchiarico Petruzzelli L, Minale B, Serio V, De Luca A, Marino Marsilia G, Campione S, et al.
G Ital Nefrol
. 2023 Jan;
39(6).
PMID: 36655832
The global coronavirus 2019 (COVID-19) pandemic required vaccination even in children to reduce infection. We report on the development of acute kidney injury (AKI) and minimal change disease (MCD) nephrotic...
9.
Martucci C, Diomedi Camassei F, Borsellino A
Ann Ital Chir
. 2023 Jan;
11.
PMID: 36606457
Aim: Median raphe cyst are uncommon malformations of male genitalia, in which are rarely described melanin pigments or melanocytes; less than ten cases have been reported in literature. The aim...
10.
De Leo E, Taranta A, Raso R, Polishchuk E, DOria V, Pezzullo M, et al.
Hum Mol Genet
. 2022 Oct;
32(7):1090-1101.
PMID: 36300303
Cysteamine is currently the only therapy for nephropathic cystinosis. It significantly improves life expectancy and delays progression to end-stage kidney disease; however, it cannot prevent it. Unfortunately, compliance to therapy...